Suchergebnisse - "Chappell, James D"

PubPharm (15)

1

Immunophenotypic predictors of influenza vaccine immunogenicity in pediatric hematopoietic cell transplant recipients

enthalten in: Blood advances | 2024

von Amarin, J. | Dulek, D. | Simmons, J. | +21

2

Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death : United States, 2022-2023

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Lewis, N. | Zhu, Y. | Peltan, I. | +148

3

SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period : a multicentre, prospective analysis

enthalten in: The Lancet. Microbe | 2024

von Raglow, Z. | Surie, D. | Chappell, J. | +24

UpdateOf: medRxiv. 2023 Aug 24;:. - PMID 37662226

4

Circulation of Rhinoviruses and/or Enteroviruses in Pediatric Patients With Acute Respiratory Illness Before and During the COVID-19 Pandemic in the US

enthalten in: JAMA network open | 2023

von Rankin, D. | Spieker, A. | Perez, A. | +32

5

Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19 : A Blinded, Randomized, Placebo-Controlled Trial

enthalten in: Chest | 2022

von Self, W. | Wheeler, A. | Stewart, T. | +49

CommentIn: Chest. 2022 Nov;162(5):e282-e283. - PMID 36344141

6

Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States : living test negative design study

enthalten in: BMJ (Clinical research ed.) | 2022

von Adams, K. | Rhoads, J. | Surie, D. | +138

UpdateOf: medRxiv. 2022 Jun 14;:. - PMID 35734090

7

Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Lewis, N. | Self, W. | Gaglani, M. | +54

8

Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Tenforde, M. | Patel, M. | Ginde, A. | +56

UpdateOf: medRxiv. 2021 Jul 08;:. - PMID 34268515

9

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States : prospective observational study

enthalten in: BMJ (Clinical research ed.) | 2022

von Lauring, A. | Tenforde, M. | Chappell, J. | +57

UpdateOf: medRxiv. 2022 Feb 07;:. - PMID 35169811

10

Intestinal Carriage of Third-Generation Cephalosporin-Resistant and Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Healthy US Children

enthalten in: Journal of the Pediatric Infectious Diseases Society | 2018

von Islam, S. | Selvarangan, R. | Kanwar, N. | +8